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Heat shock protein 70 (Hsp70) is a potent antiapoptotic
agent. Here, we tested whether it directly regulates renal cell
survival and organ function in a model of transient renal
ischemia using Hsp70 knockout, heterozygous, and wild-type
mice. The kidney cortical Hsp70 content inversely correlated
with tubular injury, apoptosis, and organ dysfunction after
injury. In knockout mice, ischemia caused changes in the
activity of Akt and glycogen synthase kinase 3-b (kinases that
regulate the proapoptotic protein Bax), increased active Bax,
and activated the proapoptotic protease caspase 3. As these
changes were significantly reduced in the wild-type mice,
we tested whether Hsp70 influences ischemia-induced
apoptosis. An Hsp70 inducer, geranylgeranylacetone,
increased Hsp70 expression in heterozygous and wild-type
mice, and reduced both ischemic tubular injury and organ
dysfunction. When administered after ischemia, this inducer
also decreased tubular injury and organ failure in wild-type
mice but did not protect the knockout mice. ATP depletion
in vitro caused greater mitochondrial Bax accumulation and
death in primary proximal tubule cells harvested from
knockout compared with wild-type mice and altered serine
phosphorylation of a Bax peptide at the Akt-specific target
site. In contrast, lentiviral-mediated Hsp70 repletion
decreased mitochondrial Bax accumulation and rescued
Hsp70 knockout cells from death. Thus, increasing Hsp70
either before or after ischemic injury preserves renal function
by attenuating acute kidney injury.
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Heat shock protein 70 (Hsp70) is a potent antiapoptotic
protein that works by simultaneously interrupting several
steps in the cell death pathway. Induction of Hsp70 by
nonlethal insults in vitro or in vivo is associated with acquired
cytoprotection.1,2 Enhanced Hsp70 expression in transgenic
mice protects the heart and brain from ischemia by an
unknown mechanism(s).3–7 Furthermore, direct injection
of Hsp70-containing adenovirus into the myocardium before
ischemia preserves contractile function.8 In the kidney,
indirect evidence suggests that Hsp70 inhibits ischemic acute
kidney injury (AKI). The Brown Norway rat, a species with
relatively abundant renal Hsp70 expression, is resistant to
ischemic AKI.9 In addition, nonspecific agents that induce
heat stress proteins reduce ischemic tissue injury, partly
by inducing the expression of Hsp70.10–12 Although previous
evidence is suggestive, a direct role for Hsp70 in ischemic AKI
has not been demonstrated and the mechanism of Hsp70-
mediated protection in ischemic tissue injury is controversial.
Recent evidence suggests that Hsp70 targets mitochon-
dria,13 a key site for integrating survival and death signal
events regulated by members of the B-cell lymphoma 2
(BCL2) protein family. In the intact kidney as well as in
renal epithelial cells subjected to ATP depletion, BCL2
proteins mediate apoptosis by causing mitochondrial mem-
brane injury, resulting in the release of caspase-dependent
and caspase-independent factors.14–21 Bax and Bcl2 (proto-
type pro- and anti-apoptotic BCL2 proteins, respectively) are
the primary mediators of survival after insults that target
mitochondria.22,23 Although other BCL2 members likely
have ‘supportive roles’ in cell death, Bax and Bcl2 determine
the apoptotic ‘set point.’24 Furthermore, maneuvers directed
at one or both of these BCL2 proteins alter stress-induced cell
death in a predictable fashion.25–29 Several laboratories,
including our own, have shown that Hsp70 regulates members
of the BCL2 family. Specifically, Hsp70 inhibits the activation
of Bax30,31 and preserves Bcl2,32,33 a Bax antagonist during cell
stress. By preventing both Bax activation and preserving Bcl2,
Hsp70 could promote cell survival.
Bax activation itself is a multistep (and hence regulable)
process that involves sequential checkpoints: confor-
mational change that exposes the N-terminal 6A7 epitope,
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oligomerization, mitochondrial translocation, and clustering
at the outer membrane.34–37 Bax activation is elegantly
regulated by stress kinases including Akt38 and glycogen
synthase kinase 3b (GSK3b).39 Stress induces 6A7 epitope
exposure either by Bax ser184 de-phosphorylation, normally
regulated by Akt,38 or by Bax ser163 phosphorylation,
regulated by GSK3b.38–40 Considerable evidence suggests that
ser184 is a key Bax regulatory site. Constitutive Bax targeting
to the mitochondrial surfaces results from either a single
substitution at this site by valine or alanine (Bax-S184V,
Bax-S184A) as well as by ser184 deletion (Bax-deltaS184).14,41
None of these Bax mutants is inactivated by Akt and each is
highly toxic to mitochondria. However, ser163 phosphory-
lation by GSK3b is also sufficient to activate Bax and induce
apoptosis.38–40 Interestingly, both ischemia in vivo and ATP
depletion in renal cells in vitro (as well as in other tissues)
simultaneously inactivate Akt and activate GSK3b.14,42 These
events might be expected, as Akt normally inactivates GSK3b.
When Akt inactivation is coupled with GSK3b activation,
site-specific serine phosphorylation events promote Bax
activation and translocation, outer mitochondrial membrane
injury, and apoptotic cell death.38,39,43
In this study, we propose that Hsp70 promotes proximal
tubule epithelial cell survival, maintains tubular structure,
and preserves organ function after acute ischemia caused by
bilateral renal pedicle occlusion (RPO). Specifically, we
hypothesized that Hsp70 reduces Bax activation and
mitochondrial injury after ischemia by modulating the
activity of Akt and GSK3b. Our results show that Hsp70
promotes renal epithelial cell survival and preserves organ
function after ischemia partly by inhibiting proapoptotic
changes in the activity of Akt and GSK3b. Furthermore, we
attempted to confirm that protection by geranylgeranylace-
tone (GGA) is causally linked to Hsp70 induction and is an
effective maneuver for preserving renal function adminis-
tered before or after an ischemic insult.
RESULTS
Hsp70.1 and Hsp70.3 gene deletion suppresses renal
Hsp70 expression
Immunoblot analysis of Hsp70 in renal cortical homo-
genates confirmed relatively high expression in Hsp70þ /þ
mice, intermediate expression in Hsp70þ / mice, and no
detectable Hsp70 in Hsp70/ mice (Figure 1). Relative
Hsp70 expression levels in the renal cortex were 100, 45±9,
and 0% for Hsp70þ /þ , Hsp70þ /, and Hsp70/ mice,
respectively (n¼ 6). Developmental defects were not detected
in any of these mice (data not shown).
Effect of Hsp70 on renal function and survival after ischemia
To assess the importance of Hsp70 as a regulator of ischemic
AKI, Hsp70þ /þ , Hsp70þ /, and Hsp70/ mice were
subjected to an intermediate duration of bilateral RPO
sufficient to induce renal dysfunction. After 25 min of RPO,
blood urea nitrogen (BUN) and creatinine increased in
all three genotypes in the following order: Hsp70/
4Hsp70þ / 4Hsp70þ /þ , indicating that the degree of
renal impairment is inversely related to Hsp70 content
(Figure 2a). In addition, 100% of Hsp70/ and 25% of
Hsp70þ / mice died within 72 h after ischemia, whereas all
Hsp70þ /þ mice survived. As a result of this variable
susceptibility to injury, the duration of pedicle occlusion
was adjusted to achieve renal dysfunction in each Hsp70
genotype in subsequent studies (that is, 21–40 min).
Effect of GGA-mediated Hsp70 induction on ischemic AKI
Hsp70þ /þ mice required more prolonged ischemia
(35–40 min) in order to achieve reversible AKI. In these
Hsp70þ /þ mice, pretreatment with GGA, an Hsp70 inducer,
significantly decreased BUN on days 1–4 after 40 min of RPO
and reduced serum creatinine on day 2, the peak time
of renal dysfunction (Figure 2b). Half of the vehicle-treated
Hsp70þ /þ mice died, whereas all GGA-treated mice
survived. In Hsp70þ / mice, GGA also reduced the severity
of renal dysfunction after 25 min of RPO, a sufficient
duration to cause reversible AKI associated with a fivefold
increase in BUN and 3.5-fold increase in serum creatinine
(Figure 2c). Preischemia treatment with GGA significantly
decreased BUN on days 1–4 after injury and reduced
creatinine by 50% in Hsp70þ / mice. Interestingly, RPO
for only 25 min caused severe AKI and death in all Hsp70/
mice (data not shown). To assess the potential efficacy of
GGA in Hsp70/ mice, the duration of RPO was shortened
to 21 min. Compared with vehicle alone, GGA failed to
improve either BUN on days 1–4 or reduce peak serum
creatinine on day 1 in postischemic mice that lack Hsp70
(Figure 2d). GGA significantly increased renal cortical Hsp70
expression (Figure 2e) by 196±14% and 104±14% in
Hsp70þ /þ and Hsp70þ / animals, respectively (Po0.05;
n¼ 6), but failed to increase its expression in Hsp70/ mice
(P40.05; n¼ 4).
Effect of Hsp70 and GGA on renal histology after ischemia
No significant morphological differences between Hsp70þ /þ
and Hsp70/ mice were detected in renal cortical tissue
sections at baseline (Figure 3a, panels A vs B). After 25 min of
RPO and 24 h of reperfusion, however, less tubular injury was
observed in the renal cortex of Hsp70þ /þ vs Hsp70/ mice
(Figure 3a, panels C vs D). Compared with Hsp70þ /þ mice,
Hsp70/ animals exhibited extensive cortical damage with
+/+ +/– –/– Hsp70 genotype
Hsp70
β-Actin
Figure 1 |Heat shock protein 70 (Hsp70) expression in mouse
genotypes. Immunoblot analysis of Hsp70 expression in renal
cortical homogenates harvested from Hsp70.1/3 wild-type
(Hsp70þ /þ ), heterozygote (Hsp70þ /), and homozygote
(Hsp70/) C57BL/6J mice; this blot is representative of six
separate studies; densitometric analysis appears in Results.
862 Kidney International (2011) 79, 861–870
or ig ina l a r t i c l e Z Wang et al.: Hsp70 prevents and treats ischemic injury
tubular dilation, epithelial cell detachment, and mild
tubulointerstitial infiltration by inflammatory cells. Most
surviving tubular epithelial Hsp70/ cells evidenced cyto-
plasmic swelling. Although evidence of renal epithelial cell
necrosis was lacking in all tissue sections, many Hsp70/
tubular cells showed nuclear chromatin condensation
indicative of apoptosis. In the medulla, the tubular lumen
was filled with hyaline material known to result from the loss
of tubular cells from more proximal nephron segments.
Before ischemia, virtually no difference in histological score
was observed between Hsp70þ /þ and Hsp70/ mice (data
not shown). However, after ischemia, the mean renal injury
score was 2.8 in Hsp70/ mice but only 1.3 in Hsp70þ /þ
mice (Po0.01 between groups; Table 1). GGA did not
alter baseline tubular morphology in either Hsp70þ /þ or
Hsp70/ mice subjected to sham ischemia (Figure 3b,
panels A vs B). In Hsp70þ /þ mice, brief RPO failed to cause
marked tubular injury in the presence or absence of GGA
(Figure 3b, panels A vs C). In contrast, 25 min of ischemia
caused significant tubular injury in Hsp70/ mice with or
without GGA (Figure 3a panel D vs panel D of Figure 3b, and
Table 1). To confirm the efficacy of GGA, Hsp70þ /þ mice
were subjected to 40 min of RPO, an insult sufficient to
produce marked tubular injury and renal dysfunction in
these animals. Compared with vehicle alone, pretreatment
with GGA effectively prevented tubular injury (Figure 3c,
panel A vs B).
Antiapoptotic role of Hsp70
The effect of renal Hsp70 expression on apoptosis, a potential
cause of ischemia-induced tubular injury and renal dysfunc-
tion, was assessed. At baseline, the content of active Bax
(a primary cause of renal epithelial cell mitochondrial
membrane injury and apoptosis) was similar in the renal
cortical homogenates harvested from Hsp70þ /þ , Hsp70þ /,
and Hsp70/ mice (Figure 4a). Bax activation during
ischemia and reperfusion, characterized by a conformational
change in the amino-terminus, occurred to the greatest
degree in Hsp70/ mice and least in Hsp70þ /þ mice. In
contrast, total Bax did not change under any experimental
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Figure 2 | Effect of heat shock protein 70 (Hsp70) deficiency or Hsp70 induction by geranylgeranylacetone (GGA) on postischemic
renal function. (a) Serum blood urea nitrogen (BUN) and creatinine at baseline and after 25min of bilateral renal pedicle occlusion (RPO)
in Hsp70þ /þ , Hsp70þ /, and Hsp70/ mice; *Po0.05 vs Hsp70þ /þ ; wPo0.05 vs Hsp70þ /þ after ischemia, n¼ 6. (b) Serum BUN and
creatinine at baseline and after 40min of bilateral RPO in Hsp70þ /þ mice with and without pretreatment with GGA; r indicates animal
death; *Po0.05 GGA vs vehicle alone; n¼ 6. (c) Serum BUN and creatinine levels at baseline and after 25min of bilateral RPO in Hsp70þ /
mice with and without GGA pretreatment; *Po0.05 for GGA vs vehicle alone; n¼ 6. (d) Serum BUN and creatinine levels at baseline and
after 21min of bilateral RPO in Hsp70/ mice with and without pretreatment with GGA; NS P40.05 for GGA vs vehicle; n¼ 6.
(e) Immunoblot analysis of Hsp70 content in renal cortical homogenates harvested from Hsp70þ /þ , Hsp70þ /, and Hsp70/ mice after
treatment with GGA (400mg/kg) or vehicle treatment; GGA increased Hsp70 expression only in Hsp70þ /þ and Hsp70þ / mice;
densitometric analysis appears in Results. GGA, 400mg/kg, was orally administered twice at 18 and 2 h before injury.
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condition in these three groups. Loss of immunoreactive Bcl2
was most remarkable in the renal cortices of Hsp70þ / and
Hsp70/ mice during perfusion. Densitometric analysis
confirmed a significant, stepwise increase in the content of
active Bax and a parallel decrease in total Bcl2 in Hsp70/
and Hsp70þ / vs Hsp70þ /þ mice (Po0.01 for Hsp70/ vs
Hsp70þ /þ mice; Po0.05 for Hsp70þ / vs Hsp70/ mice).
As a result of these reciprocal changes in active Bax and total
Bcl2, a marked increased in the Bax/Bcl2 ratio was observed
(Figure 4b). This stepwise increase in the Bax/Bcl2 ratio in
Hsp70þ /þ , Hsp70þ /, and Hsp70/ mice was associated
with a parallel increase in caspase 3 activation in the renal
Sham Ischemia (25 min)
Sham Ischemia (25 min)
Vehicle
Hsp70+/+ (40 min ischemia)
GGA
Hsp70+/+
Hsp70–/–
Hsp70+/+
plus GGA
Hsp70–/–
plus GGA
Figure 3 | Effect of pretreatment with geranylgeranylacetone
(GGA) on ischemic renal injury. (a) Representative tissue
sections from Hsp70þ /þ and Hsp70/ mice after sham renal
pedicle occlusion (RPO) vs 25min of bilateral RPO followed by
24 h of reperfusion; original magnification  400. (b) Typical injury
observed in Hsp70þ /þ and Hsp70/ mice after 25min of RPO
with 24 h of reperfusion with and without GGA pretreatment.
(c) Effect of GGA pretreatment on renal histology in Hsp70þ /þ
mice, 24 h after 40min of RPO; GGA, 400mg/kg, was administered
twice at 18 and 2 h before ischemia; tissues were stained with
hematoxylin and eosin; original magnification  400.
Table 1 | Tubular injury score
Postischemic injury Hsp70+/+ Hsp70/ Hsp70/ plus GGA
Tubular dilation 1+ 2–3+ 2–3+
Vacuolar changes 0–1+ 2+ 2
Brush border loss 2+ 3+ 3+
Cell detachment 0–1+ 2+ 2+
Nuclear condensation 0 2 2+
Intratubular casts 0 3+ 3+
Interstitial edema 1+ 2+ 2+
Leukocyte infiltration 0–1+ 2+ 2+
Capillary edema 0 2+ 2+
Abbreviations: GGA, geranylgeranylacetone; Hsp70, heat shock protein 70.
Semiquantitative grading of whole kidney cross-sections after hematoxylin and
eosin (H&E) staining. Histological injury score did not differ between any of the
above groups before 25min of ischemia (data not shown). More prolonged ischemia
was required to assess the efficacy of GGA on tubular injury in Hsp70+/+ mice
(see Figures 2b and 7a).
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Figure 4 |Apoptotic markers after renal ischemia. (a) Heat
shock protein 70 (Hsp70), active and total Bax, and B-cell
lymphoma 2 (Bcl2) content in renal cortical homogenates of
Hsp70þ /þ , Hsp70þ /, and Hsp70/ mice at baseline,
immediately after 25min of bilateral renal pedicle occlusion (RPO),
and after 60min of reperfusion; b-actin loading control (bottom
panel). (b) Densitometric analysis of active Bax (6A7), Bcl2, and the
Bax/Bcl2 ratio from at least four separate experiments; mean
active Bax and Bcl2 values, obtained after 60min of reperfusion,
were used to calculate the Bax/Bcl2 ratio in each group; *Po0.05
vs Hsp70/; n¼ 4. (c) Active (‘cleaved’) caspase 3 content in renal
cortical homogenates after 60min of reperfusion; the immunoblot
shown is representative of three separate studies; densitometric
analysis of caspase 3 data appears in Results.
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cortex (Figure 4c). Compared with Hsp70þ /þmice, active
caspase 3 increased by 548±58% and 1597±67% in the
renal cortex of Hsp70þ / and Hsp70/ animals, respec-
tively (Po0.05 vs Hsp70þ /þ ; n¼ 3).
To confirm that Hsp70 per se inhibits Bax and promotes
survival, active Bax was colocalized with a mitochondrial
marker before and after ATP depletion in cultured primary
proximal tubules cells harvested from Hsp70/ mice in
the presence and absence of exogenous Hsp70. At baseline,
virtually no active Bax was detected in cells infected
with lentivirus containing either empty vector or Hsp70
(Figure 5a, upper panels). After stress, however, active
Bax colocalized with a mitochondrial marker in Hsp70/
cells (Figure 5a, bottom panels). In Hsp70/ cells, lentiviral-
induced expression of Hsp70 to a level similar to that observed
in Hsp70þ /þ cells markedly inhibited mitochondrial Bax
accumulation and rescued the cells from death caused by ATP
depletion (Po0.01 vs empty vector; Figure 5b). Neither Hsp70
expression nor infection with empty lentivirus altered
baseline cell survival (data not shown).
Effect of Hsp70 on Akt and GSK3b: Bax regulators
As Akt and GSK3b regulate conformational Bax activation,
the effect of Hsp70 expression on the activity of these two
kinases was examined after ischemia in vivo. Basal-level Akt
activity (as measured by p-ser473 Akt content) was similar
in Hsp70þ /þ and Hsp70/ renal cortical homogenates
(Figure 6a). Compared with Hsp70/ mice, Hsp70þ /þ
cortical homogenates exhibited less Akt inactivation and
more rapid kinase reactivation (that is, greater p-ser473 Akt
content) during recovery from ischemia. Similarly, active
GSK3b (that is, p-ser9 GSK3b content) was lower in Hsp70þ /þ
vs Hsp70/ homogenates during and after stress. Compared
with Hsp70/ mice, Akt activity was 10% higher during
ischemia and nearly 75% higher during reperfusion in
Hsp70þ /þ cortical homogenates (Po0.05 for both time
points). GSK3b activity was 36% lower during ischemia
and 60% lower during recovery in Hsp70þ /þ cortical
homogenates (Po0.05; for both time points vs Hsp70/;
Figure 6b). As we recently reported GSK3b site-specific Bax
phosphorylation after ATP depletion,42 only Akt-mediated
phosphorylation of Bax ser184 was examined in a cell-free
assay using a synthetic Bax peptide substrate (Figure 6c).
Compared with ATP-replete cells, incorporation of 32[P] into
the ser184 residue was markedly reduced in immunoprecipi-
tates harvested from cultured primary proximal tubules
cell cells subjected to ATP depletion (Po0.05). These
data confirm that ATP depletion inactivates Akt and
reduces Bax ser184 phosphorylation, thereby promoting Bax
activation.
Treatment of ischemic AKI with GGA
As Hsp70 induction by GGA before ischemia ameliorated
tubular injury and organ failure, we hypothesized that GGA
effectively treats ischemic AKI. To test this hypothesis, the
severity of ischemia was reduced to 35 min and GGA was
administered twice to Hsp70þ /þ mice only after ischemia.
Compared with vehicle alone, GGA treatment resulted in
lower BUN levels, more rapid renal recovery, and increased
renal cortical Hsp70 content postischemia (Figure 7a). GGA
treatment also preserved tubular morphology after injury
(Figure 7b) and improved animal survival. Of eight vehicle-
treated Hsp70þ /þ animals, four (50%) died within
72-h postischemia. In contrast, none of the GGA-treated
Hsp70þ /þ animals died.
DISCUSSION
In this study, both endogenous and induced expressions
of Hsp70 in the murine kidney inhibit apoptosis, an
important contributor to ischemic AKI. How does Hsp70
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Figure 5 | Effect of heat shock protein 70 (Hsp70) on
mitochondrial Bax translocation and survival in primary renal
epithelial cells harvested from Hsp70/ mice. (a) Localization
of active Bax (that is, 6A7 epitope exposed; shown in red) and
mitochondria (using MitoTracker Green FM) in control (‘empty
vector’) and Hsp70-expressing (‘Hsp70 lentivirus’) proximal tubule
cells in primary culture at baseline and 6 h following 1 h of ATP
depletion; colocalization of the two probes appears as an
orange–yellow color; virtually no active Bax was detected at
baseline; results are representative of six separate studies.
(b) Effect of Hsp70 expression on survival after 1 h of ATP
depletion and 6 h of recovery in primary proximal tubule cells
harvested from Hsp70þ /þ and Hsp70/ mice in the presence of
lentivirus virus containing either empty vector or human Hsp70
(Hsp70). *Po0.05; NS, not significant. Data are mean±s.e; n¼ 7;
immunoblot analysis shows Hsp70 content in cell lysates.
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reduce mitochondrial membrane injury and apoptosis
in renal epithelial cells? As it does not interact with
Bax,30,44 we hypothesized that Hsp70 mediates events
upstream of conformational Bax activation (characterized
by exposure of the 6A7 epitope, Hetz et al.45). In our study,
renal ischemia caused a transient, 80% decrease in Akt
activity (that is, reduced ser473 Akt content; Figure 6b), and a
50% increase in GSK3b activation (that is, decreased ser9
GSK3b content; Figure 6b). We reported identical changes in
Akt and GSK3b activity in renal epithelial cells after
ATP depletion in vitro.15,42 Interestingly, Akt inactivation
results in ser9-GSK3b de-phosphorylation and activation,
biochemically linking these two kinases. During ischemic
stress, loss of Akt activity precedes conformational Bax
activation (Figure 4a), Bax translocation to mitochondria
(Figure 5a), and activation of caspase 3 (caused by
cytochrome c;46 Figure 4c), associated with decreased
cell survival (Figure 5b), marked tubular injury (Figure 3),
and loss of organ function (Figure 2a and b). In renal cell
immunoprecipitates, Akt inactivation during stress results in
serine184 de-phosphorylation of a Bax peptide (Figure 6c).
Similarly, GSK3b activation during renal ischemia promoted
ser163 phosphorylation of a Bax synthetic peptide, connecting
GSK3b activation with Bax activation in renal cells.42 In that
report, direct manipulation of GSK3b using constitutively
active and GSK3b-specific RNA interference produced
reciprocal changes in Bax activation and renal cell death after
ATP depletion, whereas RNA interference-mediated Bax
suppression prevented the toxic effects of the constitutively
active GSK3b mutant during stress, confirming that Bax is a
major target of activated GSK3b.42 In the present study,
Hsp70/ mice exhibited significantly greater GSK3b activation
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treatment on renal function and histology after renal pedicle
occlusion (RPO). (a) Serial blood urea nitrogen (BUN) at baseline
and on days 1–4 in Hsp70þ /þ mice subjected to 35min of
bilateral RPO. Mice were treated with GGA (800mg/kg
intraperitoneal (i.p.) was administered immediately after 35min of
bilateral RPO and again after 18 h of recovery) vs vehicle alone;
r indicates animal death; inset shows the effect of GGA
postischemia on heat shock protein 70 (Hsp70) content; *Po0.05 for
GGA treatment vs vehicle alone; n¼ 6. (b) Representative renal
histology in the presence of vehicle vs GGA; tissue sections stained
with hematoxylin and eosin; original magnification  400.
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(as well as more prolonged Akt inactivation) during ischemia
and reperfusion than wild-type mice (Figure 4a and b). Taken
together, these results support the hypothesis that stress-induced
changes in Akt and GSK3b alter kinase-specific Bax serine
phosphorylation, resulting in conformational Bax activation,
Bax translocation to mitochondria, and cell death.
By altering the activation of both Akt and GSK3b, we
propose that Hsp70 regulates key BCL2 proteins, apoptosis,
and renal cell injury during ischemic AKI. In fact, a stepwise
decrease in renal Hsp70 expression resulted in a stepwise
increase in both Bax activation and Bcl2 loss in cortical
homogenates (Figure 4b). Activation of Bax coupled with loss
of Bcl2 markedly increased the active Bax/Bcl2 ratio after
renal ischemia (Figure 4b) by 28-fold in Hsp70/ mice,
8-fold in Hsp70þ / mice, and by only 2.5-fold in Hsp70þ /þ
mice. This stepwise increase in the active Bax/Bcl2 ratio was
associated with a parallel increase in caspase 3 activation
(Figure 4c). Interestingly, loss of Bcl2, described as the ‘nail in
the apoptotic coffin,’ results from its degradation by
caspase 3, resulting in the conversion of Bcl2 from an anti-
to a pro-apoptotic protein.47 Our in vitro data substantiate
the role of Hsp70 as an antiapoptotic mediator. As observed
after ischemia in vivo, proximal tubule cells isolated from
Hsp70/ mice are more sensitive to ATP depletion-induced
cell death (Figure 5b). This increased sensitivity to death is
completely reversed by repletion of Hsp70 to the level
detected in wild-type mice (Figure 5b), confirming that
Hsp70 is critical for renal epithelial cell survival after stress.
Although Bax activation persists in the postischemic
period in Hsp70þ / and Hsp70/ mice (Figure 4a) and is a
potential Hsp70 target, other cytoprotective mechanisms
may be important. Hsp70 also increases cyclin D1, a key
regulator of cell proliferation,48 an important determi-
nant of renal recovery.49,50 Alternatively, by inhibiting
caspase 3 activation,51 Hsp70 could reduce the inflammation
that impairs postischemic organ recovery. This hypothesis is
supported by the observation that greater leukocyte infiltra-
tion (Table 1), a hallmark of tissue inflammation, is observed
in Hsp70/ mice.
Although a role for inducible stress proteins in regulating
survival kinases has been reported, the mechanism by
which Hsp70 regulates Akt, GSK3b, and Bax activation is
unknown. Hsp27, a potent antiapoptotic protein with similar
cytoprotective effects as Hsp70, increases the activity of
phosphatidylinositol 3-phosphate kinase, the regulatory
enzyme upstream of Akt, GSK3b,52 and Bax activation.
As Hsp70 indirectly inhibits JNK (c-jun-N-terminal kinase)
by preventing a JNK-specific phosphatase from inactivation
during stress,53 it is also possible that Hsp70 acts on the
phosphatases that regulate Akt and GSK3b. At present, it is
difficult to study the effect of Hsp70 on Bax serine
phosphorylation because of the absence of phospho-specific
antibodies and the presence of multiple serine sites with
opposing effects on Bax activity.
Resistance to ischemic AKI varied in a ‘dose-dependent’
manner that positively correlated with renal Hsp70
expression. In Hsp70/ mice, 21 min of ischemia time was
sufficient to produce moderate, reversible AKI (Figure 2d).
For Hsp70 heterozygotes, the required clamp time increased
to 25 min (Figure 2c). In contrast, Hsp70þ /þ mice needed
35–40 min of clamp time to cause AKI (Figures 2b and 7a).
GGA, a nontoxic drug currently used to treat human peptic
ulcer disease, induced Hsp70, protected tubular structure,
and preserved organ function in both wild-type and Hsp70
heterozygote mice (Figure 2b and c). However, GGA failed
to protect Hsp70 knockout mice, indicating that this agent
requires Hsp70 to afford renoprotection (Figure 2d).
Remarkably, GGA reduced the severity of ischemic AKI by
40–60% even when given during reperfusion (Figure 7a).
Finally, our study supports a role for apoptosis in the
decline in renal function after ischemia. In contrast,
morphological evidence of cell necrosis was not observed in
any of the kidney tissue sections after ischemia. Although
ischemic AKI is clinically synonymous with acute tubular
necrosis ‘ATN,’ this simplistic ‘structure-function paradigm’
has been challenged.54–56 In human renal biopsies, the
severity of ischemic ‘ATN’ fails to predict renal function,
the need for renal replacement therapy, or the likelihood of
organ recovery either in native kidneys or transplant
allografts.54 In contrast, ischemia-induced renal dysfunction
has been shown to correlate with the degree of apoptosis, at
least in rodents.55 Although apoptosis was first reported after
renal ischemia in humans nearly 20 years ago,57 its
contribution to renal failure has been difficult to quantify.58
This is partly because of the stochastic nature of apoptosis,
the evanescent nature of apoptotic cells, and the insensitivity
of current assays.58 Despite these limitations, recent evidence
strongly suggests that BCL2 protein-mediated mitochondrial
membrane injury, caspase activation, and apoptosis
contribute to renal epithelial cell death and organ
failure.15,16,21,33,42,59–61 The present observation that Hsp70,
an established antiapoptotic protein, preserves organ func-
tion adds to mounting evidence that apoptosis contributes to
ischemic AKI. To date, many treatment strategies have failed
in human trials despite their initial success in animals, partly
because of their untoward side effects. This study opens the
door to potential treatment of ischemic AKI by showing
that a nontoxic agent already in human use induces
Hsp70 in mammalian cells, limits apoptosis, and preserves
both organ structure and function even after the insult
has occurred.
MATERIALS AND METHODS
Reagents
All chemical and reagents were obtained from Sigma-Aldrich
(St Louis, MO) unless otherwise indicated.
Animals
Congenic wild-type (Charles River Laboratory, Wilmington, MA)
and Hsp70–/– mice41 were bred to produce Hsp70–/–, Hsp70þ /–, and
Hsp70þ /þ mice at the Boston University animal core facility and
were maintained under specific pathogen-free conditions. In mice,
disruption of both Hsp70.1 and Hsp70.3 genes in embryonic stem
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cells is required to completely prevent Hsp70 expression.62 Speed
congenics was utilized to transfer the deletion mutation into the
C57BL/6J mouse strain (Washington University Mouse Genetics
Core, St Louis, MO). Mice were tested through N5 and had 97.4%
conversion. All procedures were performed under conditions in
accordance with the guidelines set by the National Institutes of
Health, the Institutional Animal Care and Use Committee of Boston
Medical Center.
GGA administration
GGA (Wako Industries, cat no. 20–1573, Osaka, Japan) was
emulsified with 0.5% gum arabic and 0.008% tocopherol in distilled
water and was administered by gavage using a disposable, flexible
feeding tube. As control, the same components was prepared and
emulsified but without GGA (vehicle). Experimental mice received
GGA (400 mg/kg p.o.), 18 and 2 h before surgery, whereas control
received vehicle alone. To assess GGA as a potential treatment for
AKI, GGA was administered twice, immediately after 35 min of renal
ischemia and again 18 h later (800 mg/kg, intraperitoneal per dose).
Control animals were given an identical volume of vehicle only.
Kidney ischemia–reperfusion
Six-week-old mice weighing 20–22 g were used to perform
ischemia–reperfusion studies under standardized conditions as
recently described.42 Mice were anesthetized with intraperitoneal
injection of tribromoethanol (250 mg/kg body weight). Mice
were placed onto a sterile, warmed operating table and kidneys
were exposed by a midline incision. To control the severity of
injury, both renal arteries and veins were occluded for 25, 35, or
40 min with nontraumatic microaneurysm clamps. After clamp
removal, restoration of blood flow was visually confirmed for 1 min.
The abdomen was closed using interrupted sutures. Sham-operated
mice received identical surgical procedures except that the micro-
vascular clamps were not applied to the renal artery. For signal
transduction and histological studies, mice were killed at 0, 0.25, 1,
and 24 h after ischemia. Renal function studies (see below) were
serially performed for up to 4 days after injury, using blood drawn
from the lateral tail vein.
BUN and serum creatinine
Upon completion of the in vivo experiments, a whole-blood sample
was harvested either from the tail (BUN) or aorta (creatinine). Serum
BUN and creatinine levels were measured using QuantiChrom BUN
and or Creatinine assay kit (BioAssay System, Hayward, CA)
Histology
Kidney tissue was fixed with 10% formaldehyde, embedded in
paraffin, and cut into 8 mm sections before staining with
hematoxylin and eosin reagent. Histological scores were calculated
by a single blinded observer (RB) from 50 randomly selected cortical
tubules with visible basement membranes on cross-section using a
0–3 semiquantitative score (with ‘0’ representing normal structure
and ‘3’ representing severe injury) as previously reported.42
Kidney tissue protein extraction
Renal cortical tissue was added into prechilled RIPA buffer (Boston
BioProducts, Boston, MA) containing a 1% protease inhibitor
cocktail designed for mammalian tissue extracts and then homo-
genized. Samples were incubated for 30 min at 4 1C and centrifuged
at 16,000 g at 4 1C for 15 min to pellet the tissue debris.
The supernatant was stored at 70 1C. Protein concentrations were
determined by a colorimetric protein assay (Bio-Rad, Hercules, CA)
using protein standards.
Primary cell culture
Four-week-old mice were killed by overdose with inhaled CO2 using
established protocols. Immediately after killing, the kidneys were
removed and maintained at 4 1C (on ice). The cortex was collected,
minced, and then digested in a solution with collagenase for 60 min
at 37 1C. The collagenase was neutralized with calf serum and
the digested cortex was washed twice with buffered F12 medium.
Cells were harvested and characterized as proximal tubule in origin
as described previously by our laboratory63,64 and were maintained
in a 50:50 (vol/vol) mixture of Dulbecco’s modied Eagle’s medium
(DMEM)/Ham’s F12 medium containing insulin (5 mg/l), hydro-
cortisone (50 nM), and apotransferrin (500 mg/l) and were cultured
at 37 1C for 5–7 days in a 5% CO2 incubator.
Lentiviral-mediated Hsp70 expression
Lentivirus containing full-length human Hsp70 cDNA or empty
lentivirus was generated and renal epithelial cells were infected as
recently described by our laboratory.42 Cells were exposed to virus
for 16 h at a multiplicity of infection of 6. Hsp70 expression was
confirmed in cell lysates by immunoblot analysis 24 h after removal
of the virus.
Cell stress
ATP depletion, an established model of renal ischemia,31,46,65–67 was
induced by exposing cells to glucose-free DMEM that contained
(in mmol/l): adenosine, 1; allopurinol, 0.2; and rotenone, 10
(a mitochondrial complex I inhibitor), at 37 1C in the presence of
5% CO2 as previously reported.
67 Cells were rinsed three times with
glucose-free DMEM followed by DMEM containing the above
metabolic inhibitors for 60–90 min at 37 1C with 5% CO2. Cell
recovery was initiated by replacing the medium with DMEM
containing (in mmol/l): adenosine, 1; allopurinol, 0.2; and
heptanoic acid, 1 (to bypass complex I inhibition). These maneuvers
resulted in a 90% reduction in cell ATP content during the period
of metabolic stress and a rapid increase in ATP during recovery.67
Immunoblot analysis
Aliquots (30 g) of kidney homogenates were separated on 10%
polyacrylamide gel and transferred to a polyvinylidene fluoride
membrane. After blocking with dry milk, membranes were
incubated with antibodies directed against Hsp70 (C92F3A-5;
Stressgen, Ann Arbor, MI), active Bax (YTH-6A7; Trevingen,
Gaithersburg, MD) total Bax (YTH-5B7; Trevingen), Bcl2 (Cell
Signaling, cat no. 2876), Akt (cat no. 9272), p-ser473 Akt (cat no.
4085), GSK3b (cat no. 9332), p-ser9 GSK3b (cat no. 9336), or active
caspase 3 (cat no. 9661), 5% bovine serum albumin in Tris-buffered
saline overnight at 4 1C. Membranes were washed, incubated with
secondary antibody conjugated to horseradish peroxidase, and then
rewashed. Positive bands were detected by chemiluminescence
technology using the G:Box gel documentation and analysis system
(Fuji 4000, Tokyo, Japan). As a loading control, each membrane
was probed with an anti-b-actin antibody.
Akt-mediated Bax serine184 phosphorylation
Akt-mediated phosphorylation of a synthetic Bax peptide was
performed as previously described for GSK3b.42 In brief, Akt was
immunoprecipitated from 400mg cell protein by constant mixing
with 5 mg of an anti-Akt monoclonal antibody and protein
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A-sepharose for 2 h at 4 1C. The resulting immunoprecipitates were
added to a kinase assay wash buffer, resuspended in kinase assay
mixture (pH 7.2) to which a cAMP-dependent protein kinase
inhibitor peptide (IP20), 100 Ci [g-
32P] ATP (PerkinElmer Life Sci.,
Boston, MA) and a synthetic Bax-specific peptide (FVAGVLTASL-
TIWKKMG) that flanks the serine184 (shown in bold) were added.
The assay was terminated after 30 min of incubation at 30 1C by
spotting onto P81 ion-exchange paper. The paper was washed four
times in 0.6% phosphoric acid and bound radioactivity was
quantified by scintillation counting. A commercially available Akt
phosphorylation substrate (Upstate Biotech, Lake Placid, NY) was
used to optimize the reaction conditions.
Cell viability
In this injury model, ATP depletion causes apoptotic cell death
without necrosis,31,33,46,65,68 permitting the use of cell survival
measurements to estimate apoptosis in this model. Cell viability was
assayed using a modified colorimetric technique that is based on the
ability of live cells to convert 3-(4,5 dimethylthiazol)-2,5-diphenyl
tetrazolium bromide (MTT), a tetrazolium compound, into purple
formazan crystals as previously reported.69 The number of surviving
cells is expressed as a percentage of viable control cells detected at
baseline.
Statistical analysis
Data were analyzed using the Statview statistics program (Microsoft,
Redmond, WA). Significant differences between groups were
determined by either paired (Student’s t-test) or unpaired observa-
tions (analysis of variance using Scheffe’s test), with values of
Po0.05 considered significant.
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